Literature DB >> 21563192

EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.

Haining Zhu1, Jun Zhao, Beibei Zhu, Joanne Collazo, Jozsef Gal, Ping Shi, Li Liu, Anna-Lena Ström, Xiaoning Lu, Richard O McCann, Michal Toborek, Natasha Kyprianou.   

Abstract

BACKGROUND: Proteins on cell surface play important roles during cancer progression and metastasis via their ability to mediate cell-to-cell interactions and navigate the communication between cells and the microenvironment.
METHODS: In this study a targeted proteomic analysis was conducted to identify the differential expression of cell surface proteins in human benign (BPH-1) versus malignant (LNCaP and PC-3) prostate epithelial cells. We identified EMMPRIN (extracellular matrix metalloproteinase inducer) as a key candidate and shRNA functional approaches were subsequently applied to determine the role of EMMPRIN in prostate cancer cell adhesion, migration, invasion as well as cytoskeleton organization.
RESULTS: EMMPRIN was found to be highly expressed on the surface of prostate cancer cells compared to BPH-1 cells, consistent with a correlation between elevated EMMPRIN and metastasis found in other tumors. No significant changes in cell proliferation, cell cycle progression, or apoptosis were detected in EMMPRIN knockdown cells compared to the scramble controls. Furthermore, EMMPRIN silencing markedly decreased the ability of PC-3 cells to form filopodia, a critical feature of invasive behavior, while it increased expression of cell-cell adhesion and gap junction proteins.
CONCLUSIONS: Our results suggest that EMMPRIN regulates cell adhesion, invasion, and cytoskeleton reorganization in prostate cancer cells. This study identifies a new function for EMMPRIN as a contributor to prostate cancer cell-cell communication and cytoskeleton changes towards metastatic spread, and suggests its potential value as a marker of prostate cancer progression to metastasis.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563192      PMCID: PMC3158271          DOI: 10.1002/pros.21408

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  32 in total

1.  Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.

Authors:  Liguo Wang; Guojun Wu; Lei Yu; Jianlin Yuan; Fang Fang; Zhenbo Zhai; Fuli Wang; He Wang
Journal:  Cancer Biol Ther       Date:  2006-06-05       Impact factor: 4.742

2.  Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.

Authors:  Cathy Quemener; Eric E Gabison; Benyoussef Naïmi; Géraldine Lescaille; Faten Bougatef; Marie Pierre Podgorniak; Géraldine Labarchède; Celeste Lebbé; Fabien Calvo; Suzanne Menashi; Samia Mourah
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse.

Authors:  Nancy J Philp; Judith D Ochrietor; Carla Rudoy; Takashi Muramatsu; Paul J Linser
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

4.  Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.

Authors:  Shinichi Sakamoto; Richard O McCann; Rajiv Dhir; Natasha Kyprianou
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

5.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

6.  CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Authors:  Wei-de Zhong; Zhao-dong Han; Hui-chan He; Xue-cheng Bi; Qi-shan Dai; Gang Zhu; Yong-kang Ye; Yu-xiang Liang; Wei-jun Qin; Ze Zhang; Guo-hua Zeng; Zhi-nan Chen
Journal:  Oncology       Date:  2008-10-14       Impact factor: 2.935

7.  CD147 expression indicates unfavourable prognosis in prostate cancer.

Authors:  Zhao-dong Han; Xue-cheng Bi; Wei-jun Qin; Hui-chan He; Qi-shan Dai; Jun Zou; Yong-kang Ye; Yu-xiang Liang; Guo-hua Zeng; Zhi-nan Chen; Wei-de Zhong
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

8.  EMMPRIN-mediated MMP regulation in tumor and endothelial cells.

Authors:  Stéphanie Caudroy; Myriam Polette; Béatrice Nawrocki-Raby; Jian Cao; Bryan P Toole; Stanley Zucker; Philippe Birembaut
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.

Authors:  Li Jia; Jun Cao; Wei Wei; Shujing Wang; Yunfei Zuo; Jianing Zhang
Journal:  Int J Biochem Cell Biol       Date:  2007-06-28       Impact factor: 5.085

10.  EMMPRIN (basigin/CD147) expression is not correlated with MMP activity during adult mouse mammary gland development.

Authors:  Malgorzata Szymanowska; Kay A K Hendry; Claire Robinson; Andreas F Kolb
Journal:  J Cell Biochem       Date:  2009-01-01       Impact factor: 4.429

View more
  13 in total

1.  TGF-beta regulation of focal adhesion proteins and motility of premalignant oral lesions via protein phosphatase 1.

Authors:  Jarrett E Walsh; M Rita I Young
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

2.  Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer.

Authors:  Joanne Collazo; Beibei Zhu; Spencer Larkin; Sarah K Martin; Hong Pu; Craig Horbinski; Shahriar Koochekpour; Natasha Kyprianou
Journal:  Cancer Res       Date:  2014-02-07       Impact factor: 12.701

3.  EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study.

Authors:  Elif Bilgin Doğru; Yavuz Dizdar; Ece Akşit; Feyyaz Ural; Öner Şanlı; Vildan Yasasever
Journal:  Tumour Biol       Date:  2014-08-20

4.  Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.

Authors:  Dong Zhang; Xiao-Jie Yang; Qi-Dong Luo; Li Xue; Tie Chong
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

5.  Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.

Authors:  Marco Trerotola; Danielle L Jernigan; Qin Liu; Javed Siddiqui; Alessandro Fatatis; Lucia R Languino
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

Review 6.  Prostate cancer relevant antigens and enzymes for targeted drug delivery.

Authors:  Ashutosh Barve; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

7.  In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.

Authors:  Jingli Hao; Michele C Madigan; Aparajita Khatri; Carl A Power; Tzong-Tyng Hung; Julia Beretov; Lei Chang; Weiwei Xiao; Paul J Cozzi; Peter H Graham; John H Kearsley; Yong Li
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Role of emmprin in endometrial cancer.

Authors:  Keiichiro Nakamura; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  BMC Cancer       Date:  2012-05-28       Impact factor: 4.430

9.  CCL2 disrupts the adherens junction: implications for neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Lillie Lopez; Ignacio A Romero; Babette B Weksler; Pierre-Olivier Couraud; Joan W Berman
Journal:  Lab Invest       Date:  2012-05-28       Impact factor: 5.662

10.  The role of CD147 expression in prostate cancer: a systematic review and meta-analysis.

Authors:  Yun Ye; Su-Liang Li; Yao Wang; Yang Yao; Juan Wang; Yue-Yun Ma; Xiao-Ke Hao
Journal:  Drug Des Devel Ther       Date:  2016-08-01       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.